These final results, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the principle of targeting ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Ailments. Together with the explained https://wilhelmm956roi7.ageeksblog.com/profile